OnDemand WTP Pricing Research

Tag: pricing transparency

No One Knows The True Cost Of Medicines, And Blaming Other Countries Won’t Help | Forbes

No One Knows The True Cost Of Medicines, And Blaming Other Countries Won’t Help | Forbes

Pharmaceutical prices are arbitrary It’s a myth that the costs of medicines need to be high, to cover the research & development costs of pharmaceutical companies. Research shows that profits are much higher than necessary to justify past and future R&D, the pharma industry has one of the highest profit margins around, and the industry […]

It’s time to end the business of surprise medical bills. Here’s how. | MedCity News

It’s time to end the business of surprise medical bills. Here’s how. | MedCity News

It’s time to end the business of surprise medical bills. Here’s how. Momentum appears to be building in Congress for legislation to end so-called surprise medical bills. As a health plan CEO, I couldn’t agree more—the practice needs to end. But more legislation won’t offer a cure. The big data we need to develop a […]

Let HHS secretary negotiate lower drug prices | The Advertiser-Tribune

Let HHS secretary negotiate lower drug prices | The Advertiser-Tribune

I also introduced legislation to crack down on drug company price gouging. The Stop Price Gouging Act would protect Ohioans from prescription drug price spikes by requiring drug companies to report and justify their decisions to increase prices, and penalize companies that jack up their prices for no reason other than to pad their own […]

New rules for conveyancing | The Negotiator

New rules for conveyancing | The Negotiator

Suman Dally, Partner, Shoosmiths LLP: Price transparency only risks making the industry even more price competitive, driving down fees and consequently service. Whilst I understand the intention, I do feel the requirement for price transparency has caused confusion and created a further distraction in an industry, which has far more pressing issues around modernisation and […]

Rebates And Drug Costs: What The New Proposal Would Mean | Forbes

Rebates And Drug Costs: What The New Proposal Would Mean | Forbes

The Trump administration is trying in myriad ways to answer demands from consumers for lower prescription drug prices—a topic that got serious attention before the Senate Finance Committee on Tuesday where top executives of seven major drug companies testified. The president announced his “American Patients First” agenda in May, offering nearly 30 policy recommendations to […]

Drug pricing crisis reflected in number of bills | Lowell Sun Online

Drug pricing crisis reflected in number of bills | Lowell Sun Online

BOSTON — State lawmakers across the country have filed more than 150 bills so far this year to address the costs of prescription drugs, on the heels of passage of 45 new laws last year. Trish Riley, executive director of the National Academy for State Health Policy, said Thursday that, with uncertainty over how the […]

U.S. senators tell drug company executives pricing is ‘morally repugnant’ | Reuters

U.S. senators tell drug company executives pricing is ‘morally repugnant’ | Reuters

WASHINGTON/NEW YORK (Reuters) – U.S. senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at a Senate hearing on the rising costs of prescription medicines. … In his opening statement, Senator Ron Wyden, the Finance […]

How High Drug Prices Inflate C.E.O.s’ Pay | The New York Times

How High Drug Prices Inflate C.E.O.s’ Pay | The New York Times

Drug company executives faced tough questions from Congress on Tuesday as they attempted to explain why, thanks to high drug prices, per capita spending on pharmaceuticals in the United States is double the average of other advanced countries. For decades, American drug makers have justified these high prices by asserting that the higher profits they […]

Patient costs not linked to insurance contribution, hospital price, study finds | FierceHealthcare

Patient costs not linked to insurance contribution, hospital price, study finds | FierceHealthcare

There is almost no correlation between a patient’s out-of-pocket cost and the amount insurers pay or the overall price of a procedure, according to a Pioneer Institute study released Tuesday. The study looked at the cost for an MRI at 14 Massachusetts hospitals and found that even if there was not much of a difference in what […]

Senate Hearing On Drug Prices Reprises Past Inquiries | NPR

Senate Hearing On Drug Prices Reprises Past Inquiries | NPR

On Tuesday, Kenneth Frazier, CEO of pharmaceutical giant Merck, is set to face senators who say drug costs are “sky-high” and “out of control.” But Frazier doesn’t need new talking points. Sixty years ago, a different panel of senators grilled a different Merck boss about the same problem. To a striking degree, the subjects likely […]